Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: In vivo and in vitro evaluation of its nutraceutical potential

Journal of Functional Foods

Volumn 35, Issue , 2017, Pages 32-42

  Mollica, Adriano ^a   Zengin, Gokhan ^b   Locatelli, Marcello ^a   Stefanucci, Azzurra ^a   Mocan, Andrei ^c,d   Macedonio, Giorgia ^a   Carradori, Simone ^a   Onaolapo, Olakunle ^e   Onaolapo, Adejoke ^e   Adegoke, Juliet ^e   Olaniyan, Marufat ^e   Aktumsek, Abdurrahman ^b   Novellino, Ettore ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b Department of Biology   (Turkey)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

^e LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Capparis spinosa L; Diabetes; Flavonoids; HPLC; Nutraceuticals; Polyphenols; Amylase; Glucosidase

Indexed keywords

EID: 85019859084     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.05.001     Document Type: Article

References (52)

1. Ahmed, I., Lakhani, M., Gillett, M., John, A., Raza, H., Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice 51:3 (2001), 155–161.
2. Anwar, F., Muhammad, G., Hussain, M.A., Zengin, G., Alkharfy, K.M., Ashraf, M., Gilani, A.-H., Capparis spinosa L.: A plant with high potential for development of functional foods and nutraceuticals/pharmaceuticals. International Journal of Pharmacology 12:3 (2016), 201–219.
3. Bailey, C.J., Turner, R.C., Metformin. New England Journal of Medicine 334:9 (1996), 574–579, 10.1056/nejm199602293340906.
4. Bakr, R.O., El Bishbishy, M.H., Profile of bioactive compounds of Capparis spinosa var. aegyptiaca growing in Egypt. Revista Brasileira de Farmacognosia 26 (2016), 514–520.
5. Cameron, N.E., Gibson, T.M., Nangle, M.R., Cotter, M.A., Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Annals of the New York Academy of Sciences 1043:1 (2005), 784–792.
6. Chang, C.L., Lin, Y., Bartolome, A.P., Chen, Y.-C., Chiu, S.-C., Yang, W.-C., Herbal therapies for type 2 diabetes mellitus: Chemistry, biology, and potential application of selected plants and compounds. Evidence-Based Complementary and Alternative Medicine, 2013, 2013.
7. Cheville, N., Response to cellular injury Ultrastructural Pathology. 2000, Willey-Blackwell, Ames, Iowa, USA.
8. Eddouks, M., Lemhadri, A., Michel, J.-B., Caraway and caper: Potential anti-hyperglycaemic plants in diabetic rats. Journal of Ethnopharmacology 94:1 (2004), 143–148.
9. Eddouks, M., Lemhadri, A., Michel, J.-B., Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. Journal of Ethnopharmacology 98:3 (2005), 345–350.
10. Fernandes, A.A.H., Novelli, E.L.B., Okoshi, K., Okoshi, M.P., Di Muzio, B.P., Guimarães, J.F.C., Junior, A.F., Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomedicine & Pharmacotherapy 64:3 (2010), 214–219.
11. Hashemnia, M., Oryan, A., Hamidi, A.-R., Mohammadalipour, A., Blood glucose levels and pathology of organs in alloxan-induced diabetic rats treated with hydro-ethanol extracts of Allium sativum and Capparis spinosa. African Journal of Pharmacy and Pharmacology 6:21 (2012), 1559–1564.
12. Huang, T.H.-W., Teoh, A.W., Lin, B.-L., Lin, D.S.-H., Roufogalis, B., The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome. Pharmacological Research 60:3 (2009), 195–206.
13. Kamalakkannan, N., Prince, P.S.M., Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic & Clinical Pharmacology & Toxicology 98:1 (2006), 97–103.
14. Kazemian, M., Abad, M., reza Haeri, M., Ebrahimi, M., Heidari, R., Anti-diabetic effect of Capparis spinosa L. root extract in diabetic rats. Avicenna Journal of Phytomedicine, 5(4), 2015, 325.
15. Kirpichnikov, D., McFarlane, S.I., Sowers, J.R., Metformin: An update. Annals of Internal Medicine 137:1 (2002), 25–33.
16. Lapenna, S., Gemen, R., Wollgast, J., Worth, A., Maragkoudakis, P., Caldeira, S., Assessing herbal products with health claims. Critical Reviews in Food Science and Nutrition 55:13 (2015), 1918–1928.
17. Locatelli, M., Zengin, G., Uysal, A., Carradori, S., De Luca, E., Bellagamba, G., Lazarova, I., Multicomponent pattern and biological activities of seven Asphodeline taxa: Potential sources of natural-functional ingredients for bioactive formulations. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1 (2017), 60–67.
18. Manikandaselvi, S., Brindha, P., Chemical standardization studies on Capparis spinosa L., 6, 2014, 47–54.
19. Mocan, A., Zengin, G., Uysal, A., Gunes, E., Mollica, A., Degirmenci, N.S., Aktumsek, A., Biological and chemical insights of Morina persica L.: A source of bioactive compounds with multifunctional properties. Journal of Functional Foods 25 (2016), 94–109.
20. Mohammadi, J., Mirzaei, A., Delaviz, H., Mohammadi, B., Effects of hydroalcoholic extract of Capparis spinosa on histomorphological changes of pancreas in diabetic rats model. Journal of Birjand University of Medical Sciences 19:3 (2012), 235–244.
21. Mollica, A., Zengin, G., Locatelli, M., Stefanucci, A., Macedonio, G., Bellagamba, G., Ayileka, A., An assessment of the nutraceutical potential of Juglans regia L. leaf powder in diabetic rats. Food and Chemical Toxicology, 2017, 10.1016/j.fct.2017.03.056.
22. Nabavi, S.F., Maggi, F., Daglia, M., Habtemariam, S., Rastrelli, L., Nabavi, S.M., Pharmacological effects of Capparis spinosa L. Phytotherapy Research 30 (2016), 1733–1744.
23. Nasri, H., Baradaran, A., Shirzad, H., Rafieian-Kopaei, M., New concepts in neutraceuticals as alternative for pharmaceuticals. International Journal of Preventive Medicine 5:12 (2015), 1487–1499.
24. Niture, N.T., Ansari, A.A., Naik, S.R., Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines. Antioxidants and Lipid Biomarkers 52 (2014), 720–727.
25. OECD (2008). OECD guidelines for the testing of chemicals: Organization for economic.
26. Onaolapo, A., Onaolapo, O., Ocimum Gratissimum Linn causes dose dependent hepatotoxicity in streptozotocin-induced diabetic Wistar rats. Macedonian Journal of Medical Sciences 5:1 (2012), 17–25.
27. Onaolapo, A., Onaolapo, O., Adewole, S., Ethanolic extract of Ocimum grattissimum leaves (Linn.) rapidly lowers blood glucose levels in diabetic Wistar rats. Macedonian. Journal of Medical Sciences 4:4 (2011), 351–357.
28. Onaolapo, A.Y., Onaolapo, O.J., Adewole, S.O., Ocimum Gratissimum Linn Worsens Streptozotocin-Induced Nephrotoxicity in Diabetic Wistar Rats. Macedonian Journal of Medical Sciences 5:4 (2012), 382–388.
29. Patel, V., Sharma, V., Antioxidant and antidiabetic effect of Capparis spinosa linn. In streptozotocin induced diabetic rats. European Journal of Biomedical and Pharmaceutical Sciences 2 (2015), 308–318.
30. Pazdro, R., Burgess, J.R., The role of vitamin E and oxidative stress in diabetes complications. Mechanisms of Ageing and Development 131:4 (2010), 276–286.
31. Pournaghi, P., Sadrkhanlou, R. -A., Hasanzadeh, S., & Foroughi, A. (2012). An investigation on body weights, blood glucose levels and pituitary-gonadal axis hormones in diabetic and metformin-treated diabetic female rats. Paper presented at the Veterinary Research Forum.
32. Rahmani, R., Mahmoodi, M., Salehi, M., Effect of hydroalcoholic extract of Capparis spinosa fruit on blood sugar and lipid profile of diabetic and normal rats. Zahedan Journal of Research in Medical Sciences 15:11 (2013), 34–38.
33. Rahnavard, R., Razavi, N., A review on the medical effects of Capparis spinosa L. Advanced Herbal Medicine 2:1 (2016), 44–53.
34. Rasouli, H., Hosseini-Ghazvini, S.M.-B., Adibi, H., Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: A virtual screening perspective for the treatment of obesity and diabetes. Food & Function, 2017, 10.1039/C7FO00220C.
35. Reddy, G.B., Muthenna, P., Akileshwari, C., Saraswat, M., Petrash, J.M., Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Current Science 101:9 (2011), 1191–1197.
36. Robertson, R.P., Harmon, J., Tran, P.O.T., Poitout, V., Β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53:suppl 1 (2004), S119–S124.
37. Santini, A., Novellino, E., Nutraceuticals: Beyond the diet before the drugs. Current Bioactive Compounds 10:1 (2014), 1–12.
38. Sharaf, M., El-Ansari, M., Saleh, N., Quercetin triglycoside from Capparis spinosa. Fitoterapia 71:1 (2000), 46–49.
39. Sharma, S., Nasir, A., Prabhu, K., Murthy, P., Dev, G., Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology 85:2 (2003), 201–206.
40. Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 87:1 (2010), 4–14.
41. Siracusa, L., Kulisic-Bilusic, T., Politeo, O., Krause, I., Dejanovic, B., Ruberto, G., Phenolic composition and antioxidant activity of aqueous infusions from Capparis spinosa L. and Crithmum maritimum L. before and after submission to a two-step in vitro digestion model. Journal of Agricultural and Food Chemistry 59:23 (2011), 12453–12459.
42. Sperling, L.S., Mechanick, J.I., Neeland, I.J., Herrick, C.J., Despres, J.P., Ndumele, C.E., Grundy, S.M., The cardiometabolic health alliance: Working toward a new care model for the metabolic syndrome. Journal of the American College of Cardiology 66:9 (2015), 1050–1067, 10.1016/j.jacc.2015.06.1328.
43. Tlili, N., Khaldi, A., Triki, S., Munné-Bosch, S., Phenolic compounds and vitamin antioxidants of caper (Capparis spinosa). Plant Foods for Human Nutrition 65:3 (2010), 260–265.
44. Towler, M.C., Hardie, D.G., AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 100:3 (2007), 328–341.
45. Trombetta, D., Occhiuto, F., Perri, D., Puglia, C., Santagati, N.A., Pasquale, A.D., Bonina, F., Antiallergic and antihistaminic effect of two extracts of Capparis spinosa L. flowering buds. Phytotherapy Research 19:1 (2005), 29–33.
46. Tundis, R., Loizzo, M., Menichini, F., Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: An update. Mini Reviews in Medicinal Chemistry 10:4 (2010), 315–331.
47. Waltenberger, B., Mocan, A., Šmejkal, K., Heiss, E.H., Atanasov, A.G., Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules, 21(6), 2016, 807.
48. Xiao, J., Natural polyphenols and diabetes: Understanding their mechanism of action. Current Medicinal Chemistry 22:1 (2014), 2–3.
49. Yanardag, R., Ozsoy-Sacan, O., Bolkent, S., Orak, H., Karabulut-Bulan, O., Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Human & Experimental Toxicology 24:3 (2005), 129–135.
50. Zafar, M., Naqvi, S.N.U.H., Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: A comparative study. International Journal of Morphology 28:1 (2010), 135–142.
51. Zengin, G., A study on in vitro enzyme inhibitory properties of Asphodeline anatolica: New sources of natural inhibitors for public health problems. Industrial Crops and Products 83 (2016), 39–43.
52. Zengin, G., Locatelli, M., Ceylan, R., Aktumsek, A., Anthraquinone profile, antioxidant and enzyme inhibitory effect of root extracts of eight Asphodeline taxa from Turkey: Can Asphodeline roots be considered as a new source of natural compounds?. Journal of Enzyme Inhibition and Medicinal Chemistry 31:5 (2016), 754–759.